中国癌症防治杂志
中國癌癥防治雜誌
중국암증방치잡지
CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
2013年
3期
239-241,242
,共4页
邓腾%曾先捷%许坚%莫立根
鄧騰%曾先捷%許堅%莫立根
산등%증선첩%허견%막립근
脑肿瘤%细胞免疫功能%肿瘤WHO分级
腦腫瘤%細胞免疫功能%腫瘤WHO分級
뇌종류%세포면역공능%종류WHO분급
Intracranial neoplasms%Cellular immunity%WHO classification
目的:检测颅内肿瘤患者外周血液细胞免疫功能,探讨细胞免疫功能与WHO颅内肿瘤分级的关系,为颅内肿瘤的综合治疗提供依据。方法回顾研究2010年8月至2013年5月我科收治的79例颅内手术患者,应用流式细胞仪进行术前外周血液细胞免疫功能的检测,根据术后病理诊断明确肿瘤WHO分级。用Spearman等级相关分析法分析细胞免疫功能与肿瘤WHO分级的相关关系。结果最终纳入研究共57例患者,经Spearman等级相关分析显示,CD3+、CD4+/CD8+、CD8+、CD16+CD56+及CD19+与颅内肿瘤WHO分级无相关(P跃0.05),CD4+与颅内肿瘤WHO分级呈低度负相关(r=-0.292,P<0.05)。结论颅内肿瘤WHO分级与细胞免疫功能无明显相关关系,有待进一步研究。
目的:檢測顱內腫瘤患者外週血液細胞免疫功能,探討細胞免疫功能與WHO顱內腫瘤分級的關繫,為顱內腫瘤的綜閤治療提供依據。方法迴顧研究2010年8月至2013年5月我科收治的79例顱內手術患者,應用流式細胞儀進行術前外週血液細胞免疫功能的檢測,根據術後病理診斷明確腫瘤WHO分級。用Spearman等級相關分析法分析細胞免疫功能與腫瘤WHO分級的相關關繫。結果最終納入研究共57例患者,經Spearman等級相關分析顯示,CD3+、CD4+/CD8+、CD8+、CD16+CD56+及CD19+與顱內腫瘤WHO分級無相關(P躍0.05),CD4+與顱內腫瘤WHO分級呈低度負相關(r=-0.292,P<0.05)。結論顱內腫瘤WHO分級與細胞免疫功能無明顯相關關繫,有待進一步研究。
목적:검측로내종류환자외주혈액세포면역공능,탐토세포면역공능여WHO로내종류분급적관계,위로내종류적종합치료제공의거。방법회고연구2010년8월지2013년5월아과수치적79례로내수술환자,응용류식세포의진행술전외주혈액세포면역공능적검측,근거술후병리진단명학종류WHO분급。용Spearman등급상관분석법분석세포면역공능여종류WHO분급적상관관계。결과최종납입연구공57례환자,경Spearman등급상관분석현시,CD3+、CD4+/CD8+、CD8+、CD16+CD56+급CD19+여로내종류WHO분급무상관(P약0.05),CD4+여로내종류WHO분급정저도부상관(r=-0.292,P<0.05)。결론로내종류WHO분급여세포면역공능무명현상관관계,유대진일보연구。
Objective To investigate whether the cellular immunity status of intracranial tumors correlates with their WHO classifi-cation. Methods In this retrospective analysis of 79 patients operated on for intracranial tumors between August 2010 and May 2013,flow cytometry was used to assess levels of various T cell populations in the tumor tissue,and the WHO classification of the tis-sue was determined by postoperative pathology.Possible correlations between T cell populations and WHO classification were investi-gated using Spearman’s rank correlation. Results In the final analysis of 57 patients,levels of T cells positive for CD3+,CD4+/CD8+, CD8+,CD16+CD56+and CD19+did not correlate with WHO classification.However,the level of CD4+T cells negatively correlated with WHO classification(P<0.05). Conclusions In intracranial tumors,cellular immunity status does not significantly correlate with WHO classification.